Hinge Health Inc. Class A Common Stock vs Palantir Technologies Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B), while Palantir Technologies Inc trades at $196.05 (market cap $482.94B). The key difference: Palantir Technologies Inc is far larger — about 57× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Palantir Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Palantir Technologies Inc for 79 Days on average.
| HNGE | PLTR | |
|---|---|---|
Market Cap | $8.47B | $482.94B |
Volume | 1,624,526 | 24,103,301 |
Sector | Health | Technology |
52-Week High | $105.14 | $209.05 |
52-Week Low | $31.17 | $107.27 |
Typical Hold Time | 0 Days | 79 Days |
Enterprise Value | $8.09B | $473.74B |
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Palantir (PLTR) trades at $208.64, down slightly by 0.17% on the day, but maintains strong bullish momentum with the stock near recent highs. The company continues to demonstrate exceptional financial performance with 56.2% revenue growth in 2025, net income margin of 49%, and consistent earnings beats. Recent partnership with Armada for sovereign AI infrastructure highlights ongoing business expansion. Technical indicators show strong bullish sentiment with the stock trading above key support levels.
Palantir presents a compelling growth story with accelerating revenue and profitability, though premium valuations require continued execution. The stock faces risks from high expectations and potential growth deceleration, but strong institutional support and AI leadership provide upside potential. Current analyst consensus suggests moderate upside from current levels with 54% buy ratings.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.
Read more on PLTR →